Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

High Level EBV Persistence in the IgM + IgD + CD27 + B Cell Subset in Patients with X-Linked Lymphoproliferative Disease Lacking Isotype-Switched Memory B Cells.

Sridhar Chaganti, Cindy Ma, Andrew Bell, Debbie Croom-Carter, Andrew Hislop, Stuart Tangye, Alan Rickinson

Blood (2007) 110 (11): 2276.

https://doi.org/10.1182/blood.V110.11.2276.2276

Published: 2007

Journal Articles

Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell–directed therapy

Michael C. Milone, Donald E. Tsai, Richard L. Hodinka, Lewis B. Silverman, Alejandro Malbran, Mariusz A. Wasik, Kim E. Nichols

Blood (2005) 105 (3): 994–996.

https://doi.org/10.1182/blood-2004-07-2965

Published: 2005

Journal Articles

SLAM “dunked”?

Thomas Gross

Blood (2004) 103 (10): 3613–3614.

https://doi.org/10.1182/blood-2004-03-0779

Published: 2004

Journal Articles

SH2D1A mutations in Japanese males with severe Epstein-Barr virus–associated illnesses

Ryo Sumazaki, Hirokazu Kanegane, Maki Osaki, Takashi Fukushima, Masahiro Tsuchida, Hiroyoshi Matsukura, Kentaro Shinozaki, Hiroshi Kimura, Akira Matsui, Toshio Miyawaki

Blood (2001) 98 (4): 1268–1270.

https://doi.org/10.1182/blood.V98.4.1268

Published: 2001

Journal Articles

Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease

Janos Sumegi, Dali Huang, Arpad Lanyi, Jack D. Davis, Thomas A. Seemayer, Akihiko Maeda, George Klein, Marco Seri, Hiroshi Wakiguchi, David T. Purtilo, Thomas G. Gross

Blood (2000) 96 (9): 3118–3125.

https://doi.org/10.1182/blood.V96.9.3118

Published: 2000

NARROW

High Level EBV Persistence in the IgM + IgD + CD27 + B Cell Subset in Patients with X-Linked Lymphoproliferative Disease Lacking Isotype-Switched Memory B Cells.

Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell–directed therapy

SLAM “dunked”?

SH2D1A mutations in Japanese males with severe Epstein-Barr virus–associated illnesses

Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease

Email alerts

ASH Publications

American Society of Hematology

High Level EBV Persistence in the IgM + IgD + CD27 + B Cell Subset in Patients with X-Linked Lymphoproliferative Disease Lacking Isotype-Switched Memory B Cells.

Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell–directed therapy

SLAM “dunked”?

SH2D1A mutations in Japanese males with severe Epstein-Barr virus–associated illnesses

Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only